By Ben Griffiths | China’s clampdown on Britain’s pharmaceutical companies intensified as GlaxoSmithKline admitted its executives appeared to have broken the law, while rival AstraZeneca said it had been visited by Shanghai police. GSK last week rushed its emerging markets … Continue reading
↧